Surprisingly, in the ovarian cancer cells SKOV3, ChIP experiments showed that EZH2 could directly repress ZEB2 expression when EMT was induced in these cells following TGF-β treatment [44] suggesting that EZH2 inhibited EMT in these cells. Here, EZH2 is linked to ovarian cancer.